Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis

Published:2020-04 Issue: Volume:165 Page:105936
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Vis Roeland,van de Garde Ewoudt M.W.,Meek Bob,Korenromp Ingrid H.E.,Grutters Jan C.

Funder

Netherlands Organisation for Health Research and Development, the Netherlands

Stichting Achmea Gezondheidszorg, the Netherlands

Dutch Sarcoidosis Society, the Netherlands

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Statement on Sarcoidosis

2. Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis;Loza;Clin. Vaccine Immunol.,2011

3. Corticosteroid treatment in sarcoidosis;Grutters;Eur. Respir. J.,2006

4. Clinical presentation of sarcoidosis in The Netherlands an epidemiological study;Wirnsberger;Neth. J. Med.,1998

5. Evaluation of quality of life in sarcoidosis patients;Wirnsberger;Respir. Med.,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway;International Immunopharmacology;2024-08

2. Health-Related Quality of Life Assessment in Sarcoidosis;Clinics in Chest Medicine;2024-03

3. Anti-inflammatory Therapy for Sarcoidosis;Clinics in Chest Medicine;2024-03

4. Dexamethasone alleviates pulmonary sarcoidosis by regulating the TGF-β/Smad3 signaling to promote Th17/Treg cell rebalance;Cellular Immunology;2024-01

5. NEW TREATMENT METHODS OF SARCOIDOSIS: NARRATIVE REVIEW;Romanian Archives of Microbiology and Immunology;2023-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3